On 6/21/16, the National Institutes of Health (NIH) issued a final policy to streamline IRB review. Expectations are that a single IRB (sIRB) will be used for all non-exempt multi-site research at U.S. sites for research funded by NIH. There may be exceptions only if the sIRB cannot meet requirements. The goal is to make the IRB review process more lean and efficient for the benefit of research timelines – all while protecting patients. This policy will take effect on May 25, 2017. Click here to read the NIH notice from the Federal Register.
Contact Pearl IRB’s team at this link to help with your IRB review process. We ensure that a quality, timely review of proposed studies is conducted in the best interest of the patient, sponsor and research institution.